Science Writer
at Technology Networks
Isabel is a Science Writer and Editor at Technology Networks . She holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age.
Education
Areas of Expertise
Got a Question for Isabel Ely, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 77
News
Only 1% of Turtles Get Cancer
A new study from researchers at the University of Nottingham provides the strongest evidence to date that cancer is extremely rare in turtles.
Industry Insight
A New Era Begins for Diagnostic Testing
The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic innovation, policy and partner at Illumina Ventures, reflected on the defining moments of the last year and what lies ahead.
News
Why Humans Are More Susceptible to Cancer
Researchers at the University of California Davis Comprehensive Cancer Center have uncovered an evolutionary change that may explain why human immune cells are less effective at combating solid tumors compared to our closest living ancestors.
News
CIN Signatures Predict Chemotherapy Resistance
A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy treatments.
Industry Insight
Transforming Healthcare With Person-Centered Digital Approaches
Following the Galien Forum, Technology Networks spoke with Sanket Shah, president of Otsuka Precision Health, to learn how the company is advocating for healthcare change by combining digital innovation with meaningful human connection.
Industry Insight
Harnessing the Immune System To Combat Antimicrobial Resistance
Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.
Industry Insight
Building Trust in Cancer AI Starts With Better Data
In this conversation, Joe Day speaks about the most exciting developments in AI-powered cancer research, the critical importance of diverse, high-quality data and what it takes to build patient trust.
Article
The Gut Microbiome’s Role in Cancer Therapy Effectiveness
Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome influences the effectiveness of cancer treatments, particularly immunotherapy and chemotherapy.
Article
The Evolution of Biomarkers in Modern Cancer Care
This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.
News
Deadly Ancient Tomb Fungus Could Help Fight Cancer
Scientists have discovered a powerful anticancer compound hidden within a toxic fungus historically linked to the mysterious “Pharaoh’s curse” deaths of the first explorers to uncover the tombs of ancient kings.
Advertisement
